These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9652605)

  • 1. Insulin-sensitising agents in polycystic-ovary syndrome.
    Sattar N; Hopkinson ZE; Greer IA
    Lancet; 1998 Jan; 351(9099):305-7. PubMed ID: 9652605
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
    Iuorno MJ; Nestler JE
    Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin sensitizers for polycystic ovary syndrome.
    Baillargeon JP; Iuorno MJ; Nestler JE
    Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
    van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB
    Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218
    [No Abstract]   [Full Text] [Related]  

  • 6. Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?
    Ehrmann DA
    J Endocrinol Invest; 1998 Oct; 21(9):632-5. PubMed ID: 9856419
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
    Pugeat M
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S25-9. PubMed ID: 12773915
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
    Nestler JE
    Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Troglitazone for treatment of polycystic ovary syndrome].
    Sanaka M; Iwamoto Y
    Nihon Rinsho; 2000 Feb; 58(2):465-70. PubMed ID: 10707578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome.
    Ehrmann DA
    N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone use in polycystic ovary syndrome.
    Landman RE; Jacobs TP
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5090-1. PubMed ID: 11600596
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N; Hatzitolios AI
    Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones for treatment of polycystic ovary syndrome.
    Stout DL; Fugate SE
    Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome.
    Sangraula H; Paudel KR; Sharma M
    JNMA J Nepal Med Assoc; 2009; 48(176):335-9. PubMed ID: 21105563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.